Impact of antiepileptic drugs therapy on thyroid profile in epileptic patients of Punjab origin
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20195280Keywords:
Epilepsy, AEDs, T3, T4, TSHAbstract
Background: Epilepsy requires lifelong therapy with antiepileptic drugs (AEDs) and having medical and psychological consequence. So, the present study was conducted to evaluate the role of different AEDs on thyroid profile in epileptic patients.
Methods: 50 epileptic patients receiving AEDs for minimum 1 year were recruited as study group and 50 healthy subjects considered as control group. These subjects were recruited from general (rural or urban) community of Punjab. Fasting blood samples were drawn from patients and healthy subjects for the evaluation of triiodothyronine (T3), thyroxine (T4) and thyroid stimulating hormone (TSH) levels.
Results: Significant increase in TSH levels were recorded in epileptic patients while no significant change was found in T3 and T4 epileptic patients treated with different AEDs with respect to healthy controls. Maximum increase in TSH was seen in phenytoin, treated epileptic patients and maximum fall in TSH was recorded in levetiracetam treated epileptic patients. Maximum increase in T3 and T4 levels was found in phenytoin while a maximum decrease was recorded T3 and T4 levels in carbamazepine treated epileptic patients in comparison to other drugs treated patients.
Conclusions: Aforementioned observations suggested that epileptic patients treated with phenytoin, valproic acid, carbamazepine and levetiracetam for long time could cause initiation of subclinical hypothyroidism further could leads to overt hypothyroidism which in turn responsible for pathophysiology of various coronary heart disease. Routine screening of thyroid profile during chronic use of AEDs is recommended.
Metrics
References
Moshe SL, Percucca, Ryvlin P, Tomson T. Epilepsy: new advances. Lancet. 1971;385:884-98.
Warren TB. Diagnosis and management of epilepsy. Cand Med Assc J. 2003;168:441-56.
Amudhan S, Gururaj G, Satishchandra P. Epilepsy in India I: Epidemiology and public health. Ann Indian Acad Neurol. 2015;18(3): 263-77.
Bafitu A. Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy. Epilepsy Res. 2018;139:35-42.
Santhosh NS, Sinha SS, Satishchandra P. Epilepsy: Indian perspective. Ann Indian Acad Neurol. 2014;17:S3-11.
Cansu A. Antiepileptic drugs and hormones in children. Epilepsy Res. 2010;89:89-95.
Tamijani SMS. Thyroid hormones: Possible roles in epilepsy pathology. Seizure. 2015;31:155-64.
Nadkarni J, Uikey D, Sharma U, Dwivedi R. Effect of antiepileptic drugs on lipid profile in children with epilepsy. Inter J Med Res Rev. 2014;2:119-23.
Zhang YX. Effect of antiepileptic drug on thyroid hormones in patients with epilepsy. Seizure. 2016;35:72-9.
Svalheim S, Sveberg L, Mochol M, Taubboll E. Interactions between antiepileptic drugs and hormones. Seizure 2015;46:23-7.
Asconape JJ. Some common issues in the use of antiepileptic drugs. Semin Neurol. 2002;22(1):27-39.
Arroyo S, De La Morena A. Life-threatening adverse events of antiepileptic drugs. Epilepsy Res. 2011;47:155- 74.
Hanaya R. The new antiepileptic dugs. Neurol Med Chir (Tokyo). 2016;56:205-20.
Shih FY. Effect of antiepileptic drugs on thyroid hormone functions in epilepsy patients. Seizure. 2017;48:7-10.
